Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Makerere University | OTHER |
Not provided
Not provided
Not provided
Not provided
The study's purpose is to demonstrate the ability of an mHealth platform as a feasible way of sharing information in a time of restricted movement in order to inform future studies.
The primary objective of this trial is to assess whether an mHealth platform increases maternal health knowledge in the areas of birth preparedness, pregnancy, and birth complications as measured by the pre- and post-surveys in comparison to routine antenatal care.
The secondary objectives of this trial are;
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Intervention | Experimental | Participants in this arm will receive the study intervention. |
|
| Routine Antenatal Care | No Intervention | Participants in this arm will receive no intervention. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| mHealth Platform | Behavioral | All participants randomized to the intervention group will receive 2-4 informational texts each week and will also receive interactive health screening questions throughout enrollment. A participant will also receive appointment reminder texts. All SMS text messages will be transmitted through a local organization known as The Medical Concierge Group (TMCG) via an electronic system that allows for bulk messaging. TMCG also staffs a 24-hour call line for those using TMCG services to call in for medical related questions. This call line is staffed by doctors and nurses; SMS Maama participants randomized to the interventional group will be able to access this call line free of charge as part of their enrollment in SMS Maama. |
| Measure | Description | Time Frame |
|---|---|---|
| Change in Pre- to Post-Intervention Knowledge | Outcome is reported as the percent of pregnant participants who recognize key danger signs during pregnancy, labor and childbirth, and postpartum period. Knowledge is measured pre-intervention (approximately 24-26 weeks gestation) and post-intervention (approximately 2 weeks following delivery). The timeframe is calculated to be 16-18 weeks. | up to 18 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Change in Knowledge on COVID-19 | Outcome reported as the percent of pregnant participants who identify key symptoms, modes of transmission, and measures to prevent SARS-CoV-2 infection (COVID-19). Knowledge is measured pre-intervention (approximately 24-26 weeks gestation) and post-intervention (approximately 2 weeks following delivery). The timeframe is calculated to be 16-18 weeks. | up to 18 weeks |
Not provided
Inclusion Criteria:
Exclusion Criteria:
- Females who plan to travel out of Uganda during the study period
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Betty Nakabuye, MBChB, MMed | Lubaga Hospital and School of Public Health, Makerere University | Principal Investigator |
| Jolly Beyeza | Mulago Specialised Women's Hospital and School of Medicine, Makerere University | Principal Investigator |
| Katelyn Pastick | University of Minnesota | Principal Investigator |
| Cheryl Robertson | University of Minnesota | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Minnesota | Minneapolis | Minnesota | 55455 | United States | ||
| Makerere University |
Not provided
| ID | Term |
|---|---|
| D011248 | Pregnancy Complications |
| D001720 | Birth Injuries |
| ID | Term |
|---|---|
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D007232 | Infant, Newborn, Diseases |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Rate of COVID Testing | Outcome is reported as the percent of pregnant participants who were tested for SARS-CoV-2 during pregnancy. | up to 18 weeks |
| Change in Pregnancy Risk Knowledge | Outcome is reported as the percent of pregnant participants who believe pregnant females are at increased risk for COVID-19. Knowledge is measured pre-intervention (approximately 24-26 weeks gestation) and post-intervention (approximately 2 weeks following delivery). The timeframe is calculated to be 16-18 weeks. | up to 18 weeks |
| Change in Breastfeeding Knowledge | Outcome is reported as the percent of pregnant participants who believe it is safe to breastfeed their newborn if they have or have had COVID-19. Knowledge is measured pre-intervention (approximately 24-26 weeks gestation) and post-intervention (approximately 2 weeks following delivery). The timeframe is calculated to be 16-18 weeks. | up to 18 weeks |
| Antenatal Care Rate | Outcome is reported as the percent of pregnant participants who attend at least 4 antenatal care visits. | up to 18 weeks |
| Skilled Birth Attendance Rate | Outcome is reported as the percent of pregnant participants who give birth at a hospital. | up to 18 weeks |
| Rate of Negative Pregnancy Outcomes | Outcome is reported as the percent of pregnant participants who experience a negative pregnancy outcome (e.g. maternal/neonatal complications, miscarriage, stillbirth, and/or neonatal death). | up to 18 weeks |
| Kampala |
| Uganda |
| D014947 | Wounds and Injuries |